Latest Headlines

  1. Diazyme Laboratories, Inc. Announces CE-IVD For Its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test 4/1/2021

    Diazyme Laboratories, Inc. announced March 30th that it has obtained CE-IVD marking for its SARS-CoV-2 neutralizing antibody test. The Diazyme test is a high throughput chemiluminescent immunoassay with excellent correlation to a fluorescence based neutralization assay, which has been used to evaluate the adaptive immune response in vaccine studies.

  2. CAP Secures CMS Reapproval As Accreditation Organization 3/30/2021

    The College of American Pathologists (CAP) earned reapproval from the Centers for Medicare & Medicaid Services (CMS) as an accreditation organization for clinical laboratories.

  3. Gold Standard Diagnostics Announces FDA Clearance Of The B. burgdorferi IgG/IgM VlsE-OspC EIA Test 3/30/2021

    Gold Standard Diagnostics (GSD), a Eurofins Technologies company, today announced FDA clearance of a new B. burgdorferi IgG/IgM VlsE-OspC EIA test.

  4. Guardant Health Receives ADLT Status From CMS For FDA-Approved Guardant360 CDx Test 3/30/2021

    Guardant Health, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has approved Advanced Diagnostic Laboratory Test (ADLT) status for the Guardant360 CDx test.

  5. Affordable Single Plate Evaporator 3/30/2021

    Porvair Sciences has launched its new generation Ultravap Levante nitrogen blowdown sample evaporator.

  6. ANGLE plc Announces Global Launch Of Clinical Services Laboratories 3/30/2021

    ANGLE plc, a world-leading liquid biopsy company, is delighted to announce that it has completed the fitout and staffing of its clinical services laboratories in Guildford UK, and Plymouth Meeting PA, United States.

  7. binx Health Receives FDA CLIA Waiver For Chlamydia And Gonorrhea Test, Expanding Critical Access To Single-Visit Diagnoses 3/30/2021

    binx health, a population health technology company that provides convenient healthcare solutions, announced today that the US Food and Drug Administration (FDA) has granted Clinical Laboratory Improvement Amendments (CLIA) waiver for the binx io system, a first-of-its kind molecular point-of-care testing platform capable of delivering central laboratory quality results in about 30 minutes, for the detection of chlamydia (CT) and gonorrhea (NG).

  8. BATM Develops Molecular Diagnostics Test For Tuberculosis 3/29/2021

    BATM (LSE: BVC) (TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has developed a new method for the rapid and comprehensive diagnosis of tuberculosis ("TB").

  9. Escher Biomedical Diagnostics Announces BT-MED® COV19 Test For Detection Of COVID-19 Virus Infection In Saliva Samples 3/29/2021

    Escher Biomedical Diagnostics, LLC announced that its Escher BT-MED® COV19 Saliva Test has been accepted by FDA as a Notification under Section IV.C of the Emergency Use Authorization program.

  10. Todos Medical Completes Automation Equipment Installation And Training For A Laboratory Client In Brooklyn, NY 3/29/2021

    Todos Medical, Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening, diagnosis and immune support, as well as developing blood tests for early detection of cancer and Alzheimer’s disease, today announced the successful installation of automated lab equipment and completion of training for a lab client in Brooklyn, NY.